Based on the Kings Arms Yard Vct Plc stock forecast from 0 analysts, the average analyst target price for Kings Arms Yard Vct Plc is not available over the next 12 months. Kings Arms Yard Vct Plc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Kings Arms Yard Vct Plc is Bearish, which is based on 2 positive signals and 11 negative signals. At the last closing, Kings Arms Yard Vct Plc’s stock price was GBX 19.40. Kings Arms Yard Vct Plc’s stock price has changed by +0.00% over the past week, -2.51% over the past month and -4.43% over the last year.
No recent analyst target price found for Kings Arms Yard Vct Plc
No recent average analyst rating found for Kings Arms Yard Vct Plc
Company Overview Kings Arms Yard Vct Plc
Kings Arms Yard VCT PLC is a venture capital trust specialized in early stage and growth stage investments. The fund prefers to invest in healthcare technology, information technology, data, and artificial intelligence, fintech and communication technologies sector companies. The fund invests primarily in securities of unquoted companies and in companies whose shares are traded on Alternative Investment Market operating in the areas of information and communication technologies, and healthcare. It does not invest in companies that deal in property or shares and securities, banking, and agriculture. It invests in United Kingdom and invests in shares or securities including loans with a five year or greater maturity period. It also invests in a portfolio of listed equities and fixed interest securities. The gross assets of a portfolio company must not exceed £15 million ($17.39 million) immediately prior to the investment and £16 million ($18.55 million) immediately thereafter. The maximum each portfolio company can receive from State Aided risk capital schemes is £5 million ($5.80 million) in any twelve-month period. Portfolio companies may have up to 250 employees., including VCTs, in the 12-month period up to and including the most recent such investment. Read Less
Kings Arms Yard VCT PLC is a venture capital trust specialized in early stage and growth stage investments. The fund prefers to invest in healthcare technology, information technology, data, and artificial intelligence, fintech and communication technologies sector companies. The...Read More
Stock Target Advisor's fundamental analysis for Kings Arms Yard Vct Plc's stock is Bearish.
KAY:LSE stock's dividend yield is 5.33%.
Our analysis grades KAY:LSE stock's dividend yield at F. This means that KAY:LSE stock's dividend yield is above 59% of the stocks in the Asset Management sector in the LSE exchange.
Based on this KAY:LSE may be a average dividend stock for its sector.
Unfortunately we do not have enough data on KAY:LSE's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on KAY:LSE's stock to indicate if its overvalued.
The last closing price of KAY:LSE's stock was GBX 19.40.
The most recent market capitalization for KAY:LSE is GBX 0.11B.
Unfortunately we do not have enough analyst data on KAY:LSE's stock to indicate whether its price will go up or not.
Following are ETFs with the highest allocation to Kings Arms Yard Vct Plc's stock :
As per our most recent records Kings Arms Yard Vct Plc has 0 Employees.
Kings Arms Yard Vct Plc's registered address is 1 Benjamin Street, London, United Kingdom, EC1M 5QL.
You can get more information about it from Kings Arms Yard Vct Plc's website at https://www.albion.capital/investor-centre/our-fun.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
What not to like
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Poor return on equity
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for KAY:LSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
